• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Mar 27, 2023 at 02:32: PM
via PharmaBlock (stock code: 300725.SZSE), a global, fully integrated CDMO company focused on innovative chemistry and low-carbon manufacturing, announces the opening of its new R&D facility in West Chester, Pennsylvania. The facility expands the company's footprint in the US and enables more efficient process R&D services and fast delivery of clinical-stage GMP projects to global partners.

article source
 




Top Bottom
Back
Quote